Stockchase Opinions

Alex Ruus Neptune Tech & Bioresource NEPT-T BUY Nov 05, 2007

Sell krill oil for increasing HDL. Can’t understand the recent poor market performance as last month they announced a new Scientific Advisory board headed by Steven Nissen, chairman of the Cleveland Dept. of Cardiovascular Medicine plus 4 other renowned scientists.
$4.120

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

SHORT
For years NEPT was in partnerships where they were extracting Omega-3 oils from krill oil and selling that to consumers. Now they're taking that extraction technology and applying it to the cannabis oil market. He's in a wait-and-see spots. The fundamentals don't back the move up in the stock. He has a small short on this.
WATCH
Doesn't know this well. They're in the cannabis sector, more in the extraction market, an area that will continue to expand. He's watching their progress in earnings.